Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Necchi

Showing results (21-30 of 495) with videos related to

Pageof 50
Sort By:
Current Opinion in Urology|January 9, 2020
Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledgeMarco Bandini, Filippo Pederzoli, Andrea Necchi
European Urology|October 3, 2017
Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit NovumAndrea Necchi, Andrea Anichini, Guru Sonpavde
European Urology Oncology|November 6, 2020
Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30Massimo Alfano, Andrea Salonia, Andrea Necchi
European Urology|October 13, 2009
Re: Roisin M. Connolly, John A. McCaffrey. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review. Eur Urol 2009;56:57-64Andrea Necchi, Nicola Nicolai, Roberto Salvioni
European Urology|October 11, 2016
Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder CancerAndrea Necchi, Daniele Giardiello, Luigi Mariani
European Urology|February 18, 2024
Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMarco Moschini, Andrea Necchi, Francesco Montorsi
Current Opinion in Urology|November 12, 2024
The role of MRI in muscle-invasive bladder cancer: an update from the last two yearsGiovanni Luigi Pastorino, Chiara Mercinelli, Andrea Necchi
European Urology Focus|November 19, 2025
Bladder Preservation After Neoadjuvant Therapy for Muscle-invasive Bladder Cancer in the Current Era: Myth and RealityEmanuele Crupi, Andrea Necchi, Ashish M Kamat
European Urology|February 7, 2026
Contextualizing the Development of Anti-HER2 Therapies for Patients with Advanced Urothelial CarcinomaBrigida Anna Maiorano, Nazli Dizman, Andrea Necchi
Targeted Oncology|March 12, 2021
Coming of Age of Immunotherapy of Urothelial CancerEnrique Grande, Javier Molina-Cerrillo, Andrea Necchi
Pageof 50

Showing results (21-30 of 495) with videos related to

Sort By:
Pageof 50
Current Opinion in Urology|January 9, 2020
Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledgeMarco Bandini, Filippo Pederzoli, Andrea Necchi
European Urology|October 3, 2017
Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit NovumAndrea Necchi, Andrea Anichini, Guru Sonpavde
European Urology Oncology|November 6, 2020
Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30Massimo Alfano, Andrea Salonia, Andrea Necchi
European Urology|October 13, 2009
Re: Roisin M. Connolly, John A. McCaffrey. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review. Eur Urol 2009;56:57-64Andrea Necchi, Nicola Nicolai, Roberto Salvioni
European Urology|October 11, 2016
Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder CancerAndrea Necchi, Daniele Giardiello, Luigi Mariani
European Urology|February 18, 2024
Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMarco Moschini, Andrea Necchi, Francesco Montorsi
Current Opinion in Urology|November 12, 2024
The role of MRI in muscle-invasive bladder cancer: an update from the last two yearsGiovanni Luigi Pastorino, Chiara Mercinelli, Andrea Necchi
European Urology Focus|November 19, 2025
Bladder Preservation After Neoadjuvant Therapy for Muscle-invasive Bladder Cancer in the Current Era: Myth and RealityEmanuele Crupi, Andrea Necchi, Ashish M Kamat
European Urology|February 7, 2026
Contextualizing the Development of Anti-HER2 Therapies for Patients with Advanced Urothelial CarcinomaBrigida Anna Maiorano, Nazli Dizman, Andrea Necchi
Targeted Oncology|March 12, 2021
Coming of Age of Immunotherapy of Urothelial CancerEnrique Grande, Javier Molina-Cerrillo, Andrea Necchi
Pageof 50